Understand the technical challenges and regulatory expectations faced by biopharmaceutical development scientists and regulatory professionals during the product development lifecycle.
Securing medical devices and documents for regulatory submissions from cyberattacks is challenging. Many medical device companies struggle to retrofit their security programs to address hardening, vulnerability management, and global incident response. New statutory requirements in the United States are increasing the focus on planned postmarket activities in the submission process. Cybersecurity has become mission-critical for medical device manufacturers.
Health authorities spanning the US, European Union, Australia, Canada, and Japan have issued cybersecurity guidance that is essential for regulatory affairs professionals to understand. In addition to premarket concerns, some of the guidance also includes expectations for post-market expectations.
This interactive virtual workshop will help regulatory and quality professionals develop the knowledge they need to help steer their organizations in the right direction when it comes to global cybersecurity expectations
Technical staff will get a better understanding of how to translate regulatory expectations into concrete design and development. Organizational leaders will gain strategic knowledge that will increase the likelihood of gaining green lights from regulators while also teaching them how to establish trust with customers concerned about risk related to medical devices on their networks.
Basic: Content is introductory in nature and requires no requisite knowledge or experience to grasp concepts and related exercises. Basic educational activities are meant to establish a foundation of knowledge and/or competence that will be expanded upon in practice or in higher level activities.
|
Topic 1 An Introduction to Medical Device Cybersecurity Concepts and Challenges Speaker: Michelle Jump |
|
Topic 2 Medical Device Product Security Programs: Putting together the puzzle Speaker: Michelle Jump |
|
Topic 3a FDA Select Update, 524B, and Omnibus Speaker: Matthew Hazelett |
|
Topic 3b eSTAR: Review of the Document Expectations Speaker: Michelle Jump |
|
Topic 4 Secure Design: You Can’t Mitigate Your Way to Security Speaker: Matthew Hazelett |
|
Topic 4b SBOM Speaker: Michelle Jump |
|
Topic 5 Security Risk Management and Threat Modeling Speaker: Michelle Jump |
|
Topic 6 Submission Strategies for Cybersecurity Speaker: Matthew Hazelett |
|
Topic 6a IEC 81001-5-1: Foundational Standard for Cybersecurity Speaker: Michelle Jump |
|
Topic 7 Labeling and Communication Speaker: Michelle Jump |
|
Topic 10 Overview of global regulatory expectations Speaker: Michelle Jump |
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected]


Chief Operating Officer and Chief Quality Officer (Former FDA Cybersecurity Policy Analyst), MedSec

CEO, MedSec
Michelle Jump is the CEO of MedSec, where she is responsible for providing strategic leadership, training, and advisory services to the medical device industry in the area of cybersecurity compliance, global regulations, standards, product security program development, and security risk management.
Chief Operating Officer and Chief Quality Officer (Former FDA Cybersecurity Policy Analyst), MedSec
Matthew Hazelett is a former cybersecurity policy analyst at the US Food and Drug Administration Center for Devices and Radiological Health Office of Product Evaluation and Quality Clinical and Scientific Policy. Hazelett started at the FDA as a biomedical engineer within the Implantable Electrophysiology Devices Branch at the Center for Devices and Radiological Health (CDRH). His review areas include pacemakers, defibrillators, leads, and supporting devices, such as programmers and home monitors. Since starting at FDA, Hazelett developed a review focus on cybersecurity, participates in cybersecurity guidance development, and supports cybersecurity vulnerability assessments and reviews across CDRH. Hazelett also has worked for a medical device research and development company as a test engineer and test manager overseeing device verification and validation testing.We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.